Skip to main content
. 2021 Jun 21;10(1):1938476. doi: 10.1080/2162402X.2021.1938476

Figure 3.

Figure 3.

Sensitivity analyses of the pooled HRs for OS and PFS of cancer patients with PD-L1 expression on CTCs in the peripheral blood. A, B, Sensitivity analyses of the pooled HRs for OS. C, D, Sensitivity analyses of the pooled HRs for PFS. E, Pooled HRs and 95% CI for OS after removing two studies